Biotechnology

Filter

Current filters:

None

Popular Filters

1910 to 1934 of 2481 results

EMIG calls for greater clarity on value-based medicines from UK Parliamentary inquiry into NICE

31-10-2012

The UK Ethical Medicines Industry Group (EMIG) has welcomed the House of Commons Health Select Committee's…

BiotechnologyEuropePharmaceuticalPoliticsPricingRegulation

Medicines for normal aging conditions overtakes costs of treating most chronic diseases; Express Scripts

30-10-2012

In the USA, prescription-drug treatment regimens for conditions that are a normal part of aging are now…

BiotechnologyFinancialGenericsHealthcareNorth AmericaPharmaceutical

Menarini in $1 billion partnership with Oxford BioTherapeutics for cancer drug development

29-10-2012

In a second major deal within just over a year for the UK-based antibody-based drug developer, BioTherapeutics…

BiotechnologyLicensingMenariniOncologyOxford BioTherapeuticsPharmaceuticalResearch

The way forward in health care, by Gilbert Mertens

28-10-2012

Preparing for a future of unseen opportunity in health care requires a profound shift in thinking from…

BiotechnologyHealthcareManagementPharmaceuticalResearch

Biosimilar versions of MAbs for cancer forecast to garner sales of $4.9 billion in 2021

28-10-2012

While branded versions of monoclonal antibodies for cancer are expected to maintain sales of $6.7 million…

BiotechnologyGenericsGlobalMarkets & MarketingOncology

Celgene beats sales forecasts with strong third-quarter results

26-10-2012

US biotech company Celgene (Nasdaq; CELG) reported total revenue of $1.42 billion for the third quarter…

BiotechnologyCelgeneFinancial

Russian government to stimulate conduct of clinical trials by foreign pharma producers

25-10-2012

The Russian government plans to actively attract the world's largest pharmaceutical manufacturers to…

BiotechnologyEuropePharmaceuticalRegulationResearch

ASBMR 2012: Anabolics and post-marketing studies

25-10-2012

This year's American Society for Bone and Mineral Research (ASBMR) conference, held in Minneapolis, Minnesota,…

AmgenAnti-Arthritics/RheumaticsBiotechnologyEli LillyMerck & CoodanacatibPharmaceuticalProliaResearchteriparatideUnigene Labs

UK govt sets out proposals to cut risks for pharmaceutical research

24-10-2012

A new consultation launched yesterday by the Department for Business, Innovation & Skills (BIS) sets…

BiotechnologyEuropePatentsPharmaceuticalRegulationResearch

Amgen's third quarter 2012 sales and earnings top analysts' expectations

24-10-2012

The world's largest biotech company, USA-based Amgen (Nasdaq: AMGN), posted financial results for the…

AmgenBiotechnologyFinancial

Almirall expands in personalized medicine with 5% equity stake in AB-Biotics

24-10-2012

Spain's largest pharma company Almirall (ALM.MC) says it has reached an agreement with the Spanish biotech…

AB-BioticsAlmirallBiotechnologyMergers & AcquisitionsPharmaceuticalResearch

Gilead beats forecasts, posting 14% rise in third-quarter 2012 sales

24-10-2012

US antiviral drugs giant Gilead Sciences (Nasdaq: GILD) reported results for the third quarter of 2012,…

Anti-viralsBiotechnologyFinancialGilead Sciences

Amgen's Xgeva gets NICE backing for bone metastasis

24-10-2012

New guidance published today (October 24) by the UK's drugs watchdog the National Institute for Health…

AmgenBiotechnologyEuropeOncologyPricingRegulationXgeva

Celgene's pomalidomide meets MM-003 study endpoints

23-10-2012

US biotech firm Celgene's (Nasdaq: CELG) European subsidiary yesterday revealed that its phase III, multi-center,…

BiotechnologyCelgeneOncologypomalidomideResearch

Alnylam gets upfront $22.5 million in RNAi link with Genzyme

23-10-2012

French drug major Sanofi's (Euronext: SAN) US biotech subsidiary Genzyme has entered into an exclusive…

Alnylam PharmaceuticalsAsia-PacificBiotechnologyGenzymeLicensingPharmaceuticalRare diseasesSanofi

Actelion files for US approval of Opsumit for PAH

23-10-2012

Europe's largest biotech company Actelion (SIX: ATLN) said yesterday that it has submitted a New Drug…

ActelionBiotechnologymacitentanNorth AmericaOpsumitRegulationResearchRespiratory and Pulmonary

C4C consortium sets up France's ever facility for the industrialization of cell therapeutics

22-10-2012

The C4C consortium yesterday announced the implementation of France's first ever dedicated technical…

BiotechnologyEuropeFinancialProductionResearch

Spanish pharma R&D dips below 1 billion euros

22-10-2012

In 2011, investment in R&D in the Spanish pharmaceutical industry fell below 1.0 billion-euro ($1.3 billion)…

BiotechnologyEuropeFinancialPharmaceuticalResearch

WuXi AppTec opens first cGMP biologics facility in China

21-10-2012

China's WuXi AppTec recently hosted an inaugural Global Monoclonal Antibody Summit in conjunction with…

Asia-PacificAstraZenecaBiotechnologyProductionResearchWuXi Apptec

1910 to 1934 of 2481 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top